Bunkerhill Health has raised $55 million to scale Carebricks, an agentic AI platform used by health systems.

AI News wrote that the Series B round included continued participation from Sequoia Capital, Felicis, Optum Ventures and Y Combinator, with Khosla Ventures also named in the deal.

AI News included hospital deployment evidence rather than only research-stage claims.

It named Cleveland Clinic, the University of Texas Medical Branch and Intermountain Health as organisations running the platform today.

Carebricks Lets Hospitals Build Their Own AI Agents

According to AI News, Carebricks lets hospitals build agents rather than buy one fixed product; some agents review cardiology imaging for early signs of heart disease and flag patients needing follow-up care, while others handle prior authorisations or keep registry data current.

In a quoted company statement, Bunkerhill chief executive Nishith Khandwala said medicine has advanced faster than the healthcare system's ability to operationalise it.

Khandwala said AI agents can help health systems turn more improvement ideas into reality when workforce capacity is limited.

AI News linked the funding round to a wider US healthcare cost and staffing backdrop.

Citing the Centers for Medicare & Medicaid Services, the outlet put US healthcare spending at $5.3 trillion in 2024 and wrote that labour shortages continue to strain providers.

UTMB Runs More Than 20 Agents On Carebricks

UTMB provided the most detailed deployment account.

According to Dr Peter McCaffrey, UTMB's chief AI officer, the system has more than 20 agents live on Carebricks across clinical care, operations and administration.

AI News wrote that a Carebricks coronary-calcium agent flagged a UTMB patient during its first month of use.

The account stated that the agent used an FDA-cleared algorithm, cardiology confirmed the heart-attack risk and clinicians performed a triple bypass; UTMB's care team credited early detection with saving the patient's life.

AI News also cited UTMB-reported operational results from two other agents.

According to UTMB, the nephrology triage agent prioritises patients by severity, routes others to telemedicine and cut average specialist wait times by more than 50 percent.

For lung nodule follow-up, AI News wrote that a Carebricks agent tracks incidental findings on CT scans through to the correct follow-up.

UTMB cited an 80 percent faster response on urgent cases, a doubling of guideline-concordant follow-up and a drop in manual coordinator work.

Those clinical and operational claims remain tied to the named health system and AI News account.

The account did not provide a peer-reviewed study, patient cohort size, false-positive rate or comparative outcome data for the Carebricks deployment.

Khosla Ventures Points To Health-System Adoption

Vinod Khosla, founder of Khosla Ventures, was quoted as saying the healthcare AI bottleneck was getting a health system to run the technology, not the technology itself.

Khosla described Bunkerhill as having traction in critical health systems that most companies would take years to earn.

The round gives Bunkerhill more capital for sales and deployment work, but AI News did not present the raise as proof of measured clinical performance across all sites.

The account gives named users, UTMB deployment examples and investor comments, while leaving commercial and clinical baselines incomplete.

Bunkerhill did not disclose pricing, contract values, total patient counts, independent clinical outcome data or measured staffing savings for Carebricks deployments.